Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 9.12 CHF 1.33% Market Closed
Market Cap: CHf376.3m

Medmix Ltd
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Medmix Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Medmix Ltd
SIX:MEDX
Total Equity
CHf425.7m
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
Total Equity
CHf384.5m
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Sonova Holding AG
SIX:SOON
Total Equity
CHf2.4B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
3%
Medacta Group SA
SIX:MOVE
Total Equity
€456.6m
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Straumann Holding AG
SIX:STMN
Total Equity
CHf2.2B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Medmix Ltd
Glance View

Market Cap
376.3m CHF
Industry
Health Care

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

MEDX Intrinsic Value
LOCKED
Unlock

See Also

What is Medmix Ltd's Total Equity?
Total Equity
425.7m CHF

Based on the financial report for Dec 31, 2025, Medmix Ltd's Total Equity amounts to 425.7m CHF.

What is Medmix Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
5%

Over the last year, the Total Equity growth was -2%. The average annual Total Equity growth rates for Medmix Ltd have been -6% over the past three years , 5% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett